Concerns about storage and application of dabigatran and rivaroxaban

European Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2013, Pages 739-740

  Stöllberger, Claudia ^a   Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; RIVAROXABAN;

ANTICOAGULATION; DEMENTIA; DRUG CAPSULE; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG PACKAGING; DRUG SAFETY; DRUG STORAGE; DRUG USE; HEART ATRIUM FIBRILLATION; HEAT; HUMAN; LETTER; NASOGASTRIC TUBE; PRIORITY JOURNAL; TABLET; THERMAL EXPOSURE;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; CAPSULES; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HUMANS; HUMIDITY; MORPHOLINES; SUNLIGHT; TEMPERATURE; THIOPHENES;

EID: 84877126992     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1366-7     Document Type: Letter

References (2)

1. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
2. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883-891